Mosquito repellent spray is used in conjunction with face masks and other hygienic procedures for additional protection in the military.
On its own, it is not believed to be sufficient against the virus, although the company that produces Citriodiol has already requested the start of formal testing.
Jacqueline Watson, Managing Director of Citrefine International Ltd, said: “What we can say is that we think there is a very good chance that it could work against this virus, but of course it has to be. thoroughly tested. ”
Citriodiol is found in insect repellents such as Mosi Guard.
The British Armed Forces have decided to continue issuing the repellent due to the large number in stock.
This is because the spray did not have any negative side effects, the military used the spray without hearing the results.
JUST IN: Coronavirus map LIVE: deaths and re-infections increase
“To help them stay healthy and available for work, the Defense Department is looking at additional measures that can help their immune systems stay in shape.
Citridiol has already been used to prevent SARS 1.
Mosi-Guard containing Citridiol, is not widely sold on the main street in Britain.
It can be purchased from the Mosi-Guard and Amazon websites.
Away from the potential use of the repellant, trials for a needle-free vaccine are being developed by the University of Cambridge.
The proposed DIOS-CoVax2 vaccine could be delivered by a single jet of air.
The research team also used 3D computer modeling to analyze the structure of SARS-CoV-2.
Professor Jonathan Heeney, head of the Viral Zoonoses Laboratory at Cambridge University, and founder of DIOSynVax, said: “We are looking for cracks in his armor, crucial pieces of the virus that we can use to build the vaccine to direct. the immune response in the right direction.
“Ultimately, we aim to make a vaccine that will protect not only against SARS-CoV-2, but also other related coronaviruses that could spread from animals to humans. “